• Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Bone cell therapy company Bone Therapeutics receives 2.3 million in funding from the Wallonian Government.

Celyad commences THINK trial with its cell-based CAR-T/NKR-2 immunotherapy 

  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Bone cell therapy company Bone Therapeutics receives 2.3 million in funding from the Wallonian Government.

Celyad commences THINK trial with its cell-based CAR-T/NKR-2 immunotherapy